STERIS (STE) Reiterated at Market Outperform by Citizens on F3Q26 Top-line beat
Tweet Send to a Friend
Citizens analyst David Turkaly reiterated a Market Outperform rating and $280.00 price target on STERIS (NYSE: STE).The analyst commented, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
